Milan: gains for Philogen
(Teleborsa) - Another bullish cue from the developer of biopharmaceutical products for the treatment of life-threatening conditions as it trades with a good +2.02% gain.A comparison of the security and the FTSE Italia Mid Cap index on a weekly basis shows the greater relative strength of Philogen, confirming a better performance for the security in comparison to the related index.
The short-term scenario shows a decline towards the 20.2 Euros area with first resistance seen at 20.2. Expectations are for Philogen to continue its negative run towards support at 20.2.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 10-03-2024 09:35 AM